Share-based Payment Arrangement, Expense of RELMADA THERAPEUTICS, INC. from 30 Sep 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
RELMADA THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2013 to 31 Mar 2025.
  • RELMADA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $4,478,000, a 46% decline year-over-year.
  • RELMADA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $30,184,400, a 31% decline from 2023.
  • RELMADA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $43,811,100, a 0.87% decline from 2022.
  • RELMADA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $44,194,800, a 9.1% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,478,000 -$3,817,500 -46% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $8,295,500 -$3,059,000 -27% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $11,354,500 -$576,200 -4.8% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q1 2022 $11,930,700 +$6,079,400 +104% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $5,851,300 +$811,900 +16% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $5,039,400 +$4,644,700 +1177% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
Q1 2019 $394,700 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q3 2018 $152,800 +$83,900 +122% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2018 2019 Q1
Q3 2017 $601,300 $68,900 -$103,200 -60% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2019 Q1
Q2 2017 $704,500 $291,900 -$67,510 -19% 01 Apr 2017 30 Jun 2017 10-K 28 Sep 2018 2018 FY
Q1 2017 $772,010 $108,500 -$168,000 -61% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q3
Q4 2016 $940,010 $132,000 -$155,700 -54% 01 Oct 2016 31 Dec 2016 10-Q 10 Feb 2017 2017 Q2
Q3 2016 $1,095,710 $172,100 -$111,400 -39% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q1
Q2 2016 $1,207,110 $359,410 +$162,510 +83% 01 Apr 2016 30 Jun 2016 10-K 28 Sep 2017 2017 FY
Q1 2016 $1,044,600 $276,500 +$32,700 +13% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q3
Q4 2015 $1,011,900 $287,700 +$89,400 +45% 01 Oct 2015 31 Dec 2015 10-Q 10 Feb 2017 2017 Q2
Q3 2015 $922,500 $283,500 +$125,500 +79% 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2017 Q1
Q2 2015 $797,000 $196,900 01 Apr 2015 30 Jun 2015 10-K 09 Sep 2016 2016 FY
Q1 2015 $243,800 +$178,400 +273% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q3
Q4 2014 $198,300 01 Oct 2014 31 Dec 2014 10-Q 05 Feb 2016 2016 Q2
Q3 2014 $158,000 +$158,000 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015 2016 Q1
Q1 2014 $65,400 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q3
Q3 2013 $0 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014 2015 Q1

RELMADA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $30,184,400 -$13,626,700 -31% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $43,811,100 -$383,700 -0.87% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $44,194,800 +$3,700,300 +9.1% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 $40,494,500 +$19,717,200 +95% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $20,777,300 +$17,612,100 +556% 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022 2021 FY
2019 $3,165,200 +$2,647,200 +511% 01 Jan 2019 31 Dec 2019 10-K 24 Mar 2021 2020 FY
2018 $518,000 -$186,500 -26% 01 Jul 2017 30 Jun 2018 10-KT 26 Mar 2020 2019 FY
2017 $704,500 -$502,610 -42% 01 Jul 2016 30 Jun 2017 10-K 28 Sep 2018 2018 FY
2016 $1,207,110 +$410,110 +51% 01 Jul 2015 30 Jun 2016 10-K 28 Sep 2017 2017 FY
2015 $797,000 01 Jul 2014 30 Jun 2015 10-K 09 Sep 2016 2016 FY
2013 $382,300 01 Jan 2013 31 Dec 2013 10-K 11 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.